This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Rating Upgrade by Brokers Puts These 5 Stocks in Focus
by Maharathi Basu
Investors pursue broker advice for shaping a portfolio of lucrative stocks. Let's check out a few broker favorites like Ford (F), Bed Bath & Beyond (BBBY), Bunge (BG), Cross Country Healthcare (CCRN) and Bloomin' Brands (BLMN).
Top Ranked Momentum Stocks to Buy for November 4th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, November 4th
Are You Looking for a Top Momentum Pick? Why Bunge (BG) is a Great Choice
by Zacks Equity Research
Does Bunge (BG) have what it takes to be a top stock pick for momentum investors? Let's find out.
Bunge (BG) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Bunge (BG) delivered earnings and revenue surprises of 1135.00% and 0.99%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Top Ranked Momentum Stocks to Buy for October 28th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 28th.
Eastman Chemical (EMN) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Benefits of cost-reduction actions are expected to get reflected on Eastman Chemical's (EMN) third-quarter results.
What's in Store for Juniper (JNPR) This Earnings Season?
by Zacks Equity Research
Despite its breakthrough offerings, Juniper's (JNPR) third-quarter earnings are likely to have been hurt by macroeconomic and supply chain woes due to the COVID-19 turmoil.
Bunge (BG) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Bunge (BG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bunge (BG) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Bunge (BG) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Bunge (BG) Q2 Earnings Surpass Estimates
by Zacks Equity Research
Bunge (BG) delivered earnings and revenue surprises of 196.18% and -3.20%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Bunge (BG) This Earnings Season?
by Zacks Equity Research
Bunge (BG) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Analysts Estimate Bunge (BG) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Bunge (BG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bunge (BG) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Bunge (BG) delivered earnings and revenue surprises of -309.38% and -6.56%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Bunge (BG) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Bunge (BG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are Investors Undervaluing Bunge (BG) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy Bunge (BG) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Top Ranked Income Stocks to Buy for March 23rd
by Zacks Equity Research
Here are three stocks with buy rank and strong income characteristics for investors to consider today, March 23rd.
Is Bunge (BG) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Top Ranked Income Stocks to Buy for March 13th
by Zacks Equity Research
Here are three stocks with buy rank and strong income characteristics for investors to consider today, March 13th.
Bunge Limited Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Bunge Limited (BG) has been struggling lately, but the selling pressure may be coming to an end soon.
Top Ranked Income Stocks to Buy for March 5th
by Zacks Equity Research
Here are three stocks with buy rank and strong income characteristics for investors to consider today, March 5th.
Should Value Investors Buy Bunge (BG) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Top Ranked Income Stocks to Buy for March 3rd
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, March 3rd.
Bunge Enters Oversold Territory
by Zacks Equity Research
Bunge has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Top Ranked Income Stocks to Buy for February 28th
by Zacks Equity Research
Here are three stocks with buy rank and strong income characteristics for investors to consider today, February 28th.